ADVERTISEMENT
blood, plasma, COVID-19, SARS-CoV-2, pandemic, coronavirus, FDA, Food and Drug Administration, emergency use authorization, EUA, treatment
FDA Gives Plasma Go-Ahead to Treat COVID-19, Experts Skeptical
White House officials hail convalescent plasma as a major breakthrough, but scientists say evidence supporting its effectiveness is still lacking.
FDA Gives Plasma Go-Ahead to Treat COVID-19, Experts Skeptical
FDA Gives Plasma Go-Ahead to Treat COVID-19, Experts Skeptical

White House officials hail convalescent plasma as a major breakthrough, but scientists say evidence supporting its effectiveness is still lacking.

White House officials hail convalescent plasma as a major breakthrough, but scientists say evidence supporting its effectiveness is still lacking.

  1. Home
  2. Subjects
  3. antibody, microbiology, disease & medicine

antibody, microbiology, disease & medicine

special report
How (Not) to Do an Antibody Survey for SARS-CoV-2
Catherine Offord | Apr 28, 2020 | 10+ min read
Preprints from the first round of seroprevalence studies indicate that many more people have been infected with the virus than previously reported. Some of these studies also have serious design flaws.
coronavirus sars-cov-2 spike protein covid-19 structure glycans ace2 furin antibody
Scientists Scan for Weaknesses in the SARS-CoV-2 Spike Protein
Chris Baraniuk | Apr 9, 2020 | 5 min read
The virus’s tool for prying open host cells is coated in a protective armor of sugar—but gaps may offer vulnerability to disruption by antibodies.
Antibody Combo Knocks Down HIV in Clinical Trials
Kerry Grens | Sep 26, 2018 | 2 min read
Some patients could suppress the virus without antiretroviral therapy for months after the drug infusions.
ADVERTISEMENT
ADVERTISEMENT